Lipid Peroxidation and Antioxidant Supplementation in Neurodegenerative Diseases: A Review of Human Studies

Antioxidants
Snjezana PetrovicVesna Vucic

Abstract

Being characterized by progressive and severe damage in neuronal cells, neurodegenerative diseases (NDDs) are the major cause of disability and morbidity in the elderly, imposing a significant economic and social burden. As major components of the central nervous system, lipids play important roles in neural health and pathology. Disturbed lipid metabolism, particularly lipid peroxidation (LPO), is associated with the development of many NDDs, including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS), all of which show elevated levels of LPO products and LPO-modified proteins. Thus, the inhibition of neuronal oxidation might slow the progression and reduce the severity of NDD; natural antioxidants, such as polyphenols and antioxidant vitamins, seem to be the most promising agents. Here, we summarize current literature data that were derived from human studies on the effect of natural polyphenols and vitamins A, C, and E supplementation in patients with AD, PD, and ALS. Although these compounds may reduce the severity and slow the progression of NDD, research gaps remain in antioxidants supplementation in AD, PD, and ALS patients, which indicates that further human studies applying ant...Continue Reading

References

Aug 1, 1993·Journal of the Neurological Sciences·P Férnandez-CalleR Codoceo
Jan 21, 1993·The New England Journal of Medicine·UNKNOWN Parkinson Study Group
Mar 1, 1997·Movement Disorders : Official Journal of the Movement Disorder Society·W L Scheider Freudenheim
Jun 1, 1997·Archives of Neurology·M C de RijkA Hofman
Aug 1, 1997·Acta Neurologica Scandinavica·G P ParaskevasC Papageorgiou
Apr 27, 2000·Trends in Neurosciences·M E Rice
Jul 24, 2001·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·C DesnuelleA Favier
Apr 12, 2002·American Journal of Epidemiology·Harvey CheckowayPhillip D Swanson
Aug 10, 2002·Nutritional Neuroscience·D Allan ButterfieldVittorio Calabrese
Mar 12, 2003·Neurology·M A del AguilaG van Belle
Apr 12, 2003·Progress in Lipid Research·Koji Uchida
Sep 8, 2004·The Journal of Nutritional Biochemistry·Orly WeinrebMoussa B H Youdim
Nov 6, 2004·Annals of Neurology·Alberto AscherioMichael J Thun
Nov 13, 2004·Annals of Internal Medicine·Edgar R MillerEliseo Guallar
Dec 23, 2004·Clinical Neuropharmacology·Hiroshi NagayamaYasuo Katayama
Jan 15, 2005·Antioxidants & Redox Signaling·Thomas J MontineJason D Morrow
Apr 15, 2005·The New England Journal of Medicine·Ronald C PetersenUNKNOWN Alzheimer's Disease Cooperative Study Group
Mar 1, 2006·Biochimica Et Biophysica Acta·Francois Gros-LouisGuy A Rouleau
Oct 3, 2006·Neurobiology of Disease·Richard E HartmanDavid M Holtzman
Jan 27, 2007·The Cochrane Database of Systematic Reviews·R G MillerD H Moore
Jan 27, 2007·The Cochrane Database of Systematic Reviews·R W OrrellM Ross
Oct 9, 2007·The Journal of Biological Chemistry·Wen-Liang SongGarret A FitzGerald
Nov 10, 2007·The American Journal of Clinical Nutrition·Xiang GaoAlberto Ascherio
Dec 26, 2007·Molecular Aspects of Medicine·Giuseppe PoliGabriella Leonarduzzi
Jun 25, 2008·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Hiroshi MitsumotoPam Factor-Litvak

❮ Previous
Next ❯

Citations

Apr 4, 2021·Antioxidants·Consuelo Cháfer-Pericás
May 1, 2021·Pharmaceuticals·Maria Grazia MorgeseLuigia Trabace
Aug 24, 2021·Frontiers in Nutrition·Maja MiloševićVesna Vučić

❮ Previous
Next ❯

Methods Mentioned

BETA
MDA
transgenic

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.